GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Piotroski F-Score

CBLL (CeriBell) Piotroski F-Score


View and export this data going back to 2024. Start your Free Trial

What is CeriBell Piotroski F-Score?

CeriBell does not have enough data to calculate Piotroski F-Score.


CeriBell Piotroski F-Score Historical Data

The historical data trend for CeriBell's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell Piotroski F-Score Chart

CeriBell Annual Data
Trend Dec22 Dec23
Piotroski F-Score
- -

CeriBell Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
Piotroski F-Score - - - -

CeriBell  (NAS:CBLL) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


CeriBell Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of CeriBell's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


CeriBell Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

CeriBell Headlines

From GuruFocus